Haematological malignancies
Gene: MDM4
PMID 41758987 adds five novel families with heterozygous loss‑of‑function or missense MDM4 variants, expanding the cohort to six unrelated families with bone‑marrow failure, cytopenias, hypocellular marrow, telomere shortening and cancer predisposition. Detailed phenotypes and segregation are reported, and functional validation includes CRISPR‑edited CD34⁺ HSPCs, iPSC‑derived progenitors and rescue by TP53 loss, complementing the mouse knock‑in model described by PMID 32300648.Created: 17 Mar 2026, 6:49 p.m. | Last Modified: 17 Mar 2026, 6:49 p.m.
Panel Version: 0.75
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
bone marrow failure syndrome 6, MONDO:0030015
Publications
A single family was reported to segregate a missense variant (p.Thr454Met) with features suggestive of dyskeratosis congenita, e.g., bone marrow hypocellularity, short telomeres, tongue squamous cell carcinoma, and acute myeloid leukemia. A mouse model of p.Thr454Met showed increased p53 activity, decreased telomere length, and bone marrow failure.
Sources: OtherCreated: 14 Nov 2023, 11:16 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
bone marrow failure syndrome MONDO:0000159, MDM4-related
Publications
Gene: mdm4 has been classified as Green List (High Evidence).
Phenotypes for gene: MDM4 were changed from bone marrow failure syndrome MONDO:0000159, MDM4-related to bone marrow failure syndrome 6, MONDO:0030015
Publications for gene: MDM4 were set to 32300648; 33104793
Gene: mdm4 has been classified as Green List (High Evidence).
gene: MDM4 was added gene: MDM4 was added to Haematological malignancies cancer susceptibility. Sources: Expert Review Amber,Other Mode of inheritance for gene: MDM4 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: MDM4 were set to 32300648; 33104793 Phenotypes for gene: MDM4 were set to bone marrow failure syndrome MONDO:0000159, MDM4-related